Form 4: CEO David Rosa Achieves Intuitive Surgical PSU Targets

Intuitive Surgical CEO David J. Rosa has achieved performance metrics for multiple tranches of Performance Stock Units, leading to future vesting.

Summary

• David J. Rosa, Chief Executive Officer and Director of Intuitive Surgical Inc. (ISRG), reported on the achievement of performance criteria for several tranches of Performance Stock Units (PSUs).
• Performance criteria for 6,360 PSUs initially granted on February 26, 2024, have been achieved, as determined by the Compensation Committee.
• Performance criteria for 9,575 PSUs initially granted on February 28, 2023, have been achieved, as determined by the Compensation Committee.
• Performance criteria for 6,034 PSUs initially granted on June 12, 2023, have been achieved, as determined by the Compensation Committee.
• These PSUs will vest on February 26, 2027 (for the 2024 grant), February 28, 2026 (for the February 2023 grant), and February 28, 2026 (for the June 2023 grant), subject to Mr. Rosa's continuous service to the Issuer through each vesting date.
• The reported transaction date for these achievements is January 28, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as the CEO has met performance targets, reflecting well on the company's operational execution and goal attainment.

Positives

• Performance criteria for multiple tranches of Performance Stock Units granted to CEO David J. Rosa have been achieved.
• This indicates successful attainment of pre-defined company performance metrics as determined by the Compensation Committee of Intuitive Surgical Inc.

Future Outlook

The achievement of performance metrics for these PSUs sets the stage for their future vesting on specified dates, contingent on the CEO's continuous service to Intuitive Surgical Inc.

Industry Context

StockSavvy.ai notes that the achievement of performance-based compensation targets by a CEO is a common indicator of a company meeting its internal operational or financial goals, which can be viewed positively by the market, especially in the competitive medical device and surgical robotics industry where innovation and market penetration are key.

Stakeholder Impact

• Shareholders: Positive, as the achievement of performance metrics by the CEO suggests the company is meeting its strategic and operational goals, which can contribute to long-term value creation.

Next Steps

• Vesting of 6,360 PSUs on February 26, 2027, subject to continuous service.
• Vesting of 9,575 PSUs on February 28, 2026, subject to continuous service.
• Vesting of 6,034 PSUs on February 28, 2026, subject to continuous service.

Key Dates

Keywords

Intuitive Surgical, ISRG, David J. Rosa, CEO, Performance Stock Units, PSUs, Executive Compensation, Insider Transaction, Corporate Governance